Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet. 2010 Nov 6;376(9752):1604-15. doi: 10.1016/S0140-6736(10)61355-4. Epub 2010 Oct 28.

Costs and financial feasibility of malaria elimination.

Author information

1
Clinton Health Access Initiative, Boston, MA 02127, USA. osabot@clintonhealthaccess.org

Abstract

The marginal costs and benefits of converting malaria programmes from a control to an elimination goal are central to strategic decisions, but empirical evidence is scarce. We present a conceptual framework to assess the economics of elimination and analyse a central component of that framework-potential short-term to medium-term financial savings. After a review that showed a dearth of existing evidence, the net present value of elimination in five sites was calculated and compared with effective control. The probability that elimination would be cost-saving over 50 years ranged from 0% to 42%, with only one site achieving cost-savings in the base case. These findings show that financial savings should not be a primary rationale for elimination, but that elimination might still be a worthy investment if total benefits are sufficient to outweigh marginal costs. Robust research into these elimination benefits is urgently needed.

PMID:
21035839
PMCID:
PMC3044845
DOI:
10.1016/S0140-6736(10)61355-4
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center